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Abstract: 
 
We previously reported that in young adult males growth hormone (GH) release is related to 
exercise intensity in a linear dose-response manner (Pritzlaff et al. J Appl Physiol 87: 498–504, 
1999). To investigate the effects of gender and exercise intensity on GH release, eight women 
(24.3 ± 1.3 yr, 171 ± 3.2 cm height, 63.6 ± 8.7 kg weight) were each tested on six randomly 
ordered occasions [1 control condition (C), 5 exercise conditions (Ex)]. Serum GH 
concentrations were measured in samples obtained at 10-min intervals between 0700 and 0900 
(baseline) and 0900 and 1300 (Ex + recovery or C). Integrated GH concentrations (IGHC) were 
calculated by trapezoidal reconstruction. During Ex, subjects exercised for 30 min (0900–0930) 
at one of the following intensities [normalized to the lactate threshold (LT)]: 25 and 75% of the 
difference between LT and rest, at LT, and at 25 and 75% of the difference between LT and peak 
O2 uptake. No differences were observed among conditions for baseline IGHC. To determine 
whether total (Ex + recovery) IGHC changed with increasing exercise intensity, slopes 
associated with individual linear regression models were subjected to a Wilcoxon signed-rank 
test. To test for gender differences, data in women were compared with the previously published 
data in men. A Wilcoxon ranked-sums two-tailed test was used to analyze the slopes and 
intercepts from the regression models. Total IGHC increased linearly with increasing exercise 
intensity. The slope and intercept values for the relationship between total IGHC and exercise 
intensity were greater in women than in men. Deconvolution analysis (0700–1300 h) revealed 
that, regardless of gender, increasing exercise intensity resulted in a linear increase in the mass of 
GH secreted per pulse and summed GH production rate, with no changes in GH secretory pulse 
frequency or apparent half-life of elimination. Exercise reduced the half-duration of GH 
secretory burst in men but not in women. Gender comparisons revealed that women had greater 
basal (nonpulsatile) GH secretion across all conditions, more frequent GH secretory pulses, a 
greater GH secretory pulse amplitude, a greater production rate, and a trend for a greater mass of 
GH secreted per pulse than men. We conclude that, in young adults, the GH secretory response 
to exercise is related to exercise intensity in a linear dose-response pattern. For each incremental 
increase in exercise intensity, the fractional stimulation of GH secretion is greater in women than 
in men. 
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Article: 
 
Acute exercise is a powerful stimulus to growth hormone (GH) release (2-5, 15, 17, 20, 32, 33). 
Previous research has suggested that exercise intensity plays a key role, wherein a particular 
threshold of exercise intensity must be exceeded to elicit GH release (3-5). However, recent data 
from our laboratory indicate that, in young men, the magnitude of GH release rises with 
increasing exercise intensity in a linear dose-response relationship (as opposed to a threshold 
relationship) (20). Whether females have similar GH responses to varying exercise intensities is 
not known. 
 
GH release at rest is greater in young women than in comparably aged men (7, 26, 30, 34). This 
gender difference is accounted for by a twofold greater mass of GH secreted per burst in young 
women (26, 30). Wideman et al. (34) reported that women have higher serum GH concentrations 
at rest and during a single exercise intensity and attain their peak GH concentration sooner than 
men. Despite gender differences in the absolute values of GH release during rest and aerobic 
exercise, the relative response to a single exercise intensity was similar in men and in women 
(34). 
 
The present investigation examines the joint effects of gender and exercise intensity on GH 
secretion by comparing data collected on women with our previously published data on men 
(20). We hypothesized that the GH secretory response pattern to varying exercise intensities 
would be similar in men and women. On the basis of previously reported gender differences in 
GH secretion, we further hypothesized that the magnitude of change in GH release with 
increasing exercise intensity would be greater in women than in men. Characterization of these 
gender-based responses during exercise should provide insight into potential mechanisms 
underlying gender differences in GH release during exercise. 
 
METHODS 
 
Subjects and preliminary screening procedures. Eight recreationally active women between the 
ages of 18 and 35 yr (mean age = 24.3 ± 1.3 yr, height = 171 ± 3.2 cm, weight = 63.6 ± 8.7 kg) 
participated after they provided voluntary written, informed consent, as approved by the Human 
Investigation Committee of the University of Virginia. Each subject underwent a detailed 
medical history and physical examination, and no subject had a history of hypothalamopituitary, 
renal, hepatic, hematalogical, or metabolic disease. The subjects were nonsmokers, did not abuse 
alcohol, and were not taking any systemic medications. Screening laboratory data revealed 
normal hematological, renal, hepatic, metabolic, and thyroid function. Subjects refrained from 
exercise for 24 h before each evaluation. 
 
Body composition analysis. Body density was determined by hydrostatic weighing (14). Each 
subject was weighed in air on an Accu-weigh beam scale accurate to +0.1 kg and subsequently 
weighed underwater on a Chatillon autopsy scale accurate to +0.01 kg. Water temperature in the 
tank was maintained between 36 and 39°C. Residual lung volume was measured with the use of 
an oxygen-dilution technique (36). The computational procedure of Brozek et al. (1) was used to 
determine percent body fat from body density measurements. 
 
Peak O2 uptake and lactate threshold test. Peak O2 uptake (V˙o2 peak) and lactate threshold (LT) 
were evaluated via a continuous treadmill (Quinton Q65 treadmill) exercise protocol with 
increasing velocity until volitional fatigue. The initial velocity was set at 80 m/min, with 
increases in velocity of 10 m/min every 3 min. Open-circuit spirometry was used to collect 
metabolic data (SensorMedics model 2900Z metabolic measurement cart, Yorba Linda, CA). 
Heart rate was determined via a Marquette Max-1 electrocardiograph. An indwelling cannula 
was inserted into a forearm vein before subjects were tested, and blood samples were taken at 
rest and during the last 15 s of each stage for the measurement of blood lactate concentration 
(Yellow Springs Instruments 2700 Select Biochemistry Analyzer, Yellow Springs, 
OH).V˙o2 peak was chosen as the highest O2 consumption (V˙o2) attained. 
 
Determination of LT and the constant load treadmill velocities. The blood lactate-velocity 
relationship was determined by plotting blood lactate concentration against treadmill velocity. 
LT was chosen as the highest velocity obtained before the curvilinear increase in blood lactate 
concentration. An elevation in blood lactate concentration of at least 0.2 mM (the error 
associated with the lactate analyzer) above baseline was required for LT 
determination.V˙o2 associated with velocity LT was then determined (31). 
 
Exercise admissions consisted of 30 min of constant load exercise at a predetermined velocity. 
Treadmill velocity was set at 25 and 75% of the difference between the V˙o2 at LT and V˙o2 at 
rest (0.25LT and 0.75LT, respectively), at LT, and at 25 and 75% of the difference between 
theV˙o2 at LT andV˙o2 peak (1.25LT and 1.75LT, respectively), based on results obtained during 
the initial LT-V˙o2 peak protocol. 
 
General clinical research center admissions. After the initial exercise test, each subject was 
studied at the general clinical research center (GCRC) on a total of six separate occasions, five 
with exercise and one at rest. The order of study conditions was assigned in a randomized 
fashion. The admissions were scheduled in the early follicular phase of the menstrual cycle, with 
no more than two admissions over a 2-mo time frame allowed (to ensure that guidelines for 
blood withdrawal were not exceeded). Although a minimum of six menstrual cycles were 
required for each subject to complete the study, the randomly assigned GCRC admissions and 
the selection of habitually active subjects likely minimized any changes in aerobic fitness, LT, 
and/or body composition that might have confounded the data. Subjects were admitted to the 
GCRC on the evening before the exercise and control studies. Subjects were required to consume 
their evening meal at or before 1700 h and then received a standardized snack (500 kcal) at 2000 
h. The nutrient composition of the snack was 55% carbohydrate, 15% protein, and 30% fat. 
Subjects were allowed to consume water ad libitum. To avoid the confounding effects of meals 
on GH secretion, subjects then fasted until the end of the study (8, 9). At 2100 h, an intravenous 
cannula was placed bilaterally in each forearm vein. Subjects remained at the GCRC after eating 
their snack and were asked to turn lights off by 2300 h (9, 11). Beginning at 0700 h, blood 
samples were withdrawn every 10 min until 1300 h for later measurement of serum GH 
concentrations. 
 
Exercise admission. After 2 h of baseline blood sampling was conducted, subjects began their 
exercise bout at the predetermined velocity. The exercise bout began at 0900 h and continued 
until 0930 h. During the exercise bout, blood lactate was measured every 10 min and metabolic 
data were measured minute by minute. The respiratory exchange ratio was measured using open-
circuit spirometry (SensorMedics 2900Z metabolic measurement cart) during exercise and 
during the 30 min immediately after exercise while the subject sat quietly in the exercise lab. 
Thereafter, subjects resumed bed rest until 1300 h when the test was terminated and vital signs 
were taken. Subjects were then fed and discharged. 
 
Nonexercise admission. The above procedure was also followed on the nonexercise days. 
However, at 0900 h, subjects remained in their rooms and rested quietly until 1300 h. At this 
time, the cannulas were removed and vital signs were taken. Subjects were fed and discharged. 
 
GH assay. GH concentrations were measured in duplicate by using the modified Nichols 
ultrasensitive chemiluminescence assay (13). The optimized assay consists of 200 μl of serum 
assayed in duplicate with 200 μl of GH antiserum, overnight shaking incubation, robotic 
pipetting, and automated washing of the antibody-coated polystyrene beads (Nichols 
Laboratories, San Juan Capistrano, CA). Assay sensitivity, defined as 3 SD above the zero-dose 
tube, was 0.005 μg/l, and that defined as 2 SD above the zero-dose tube was 0.002 μg/l (13). 
Recombinant human GH (22,000 Da) was used as the reference standard. All samples from a 
subject were assayed together to eliminate interassay variability. 
 
Data reduction. Assay data were analyzed by a model-free dose-dependent extrapolation of 
triplicate standards (23). Mean and integrated serum GH concentrations over 6 and 4 h (0900–
1300 h) [integrated GH concentration (IGHC)] were calculated as outlined by Veldhuis and 
Johnson (27) using Cluster version 6.01. 
 
Deconvolution. A multiple-parameter deconvolution method was employed to estimate the 
attributes of GH secretory events from the measured serum GH concentrations for the entire 6-h 
time period (28). The subject-specific monoexponential half-life of apparent metabolic removal 
of endogenous GH was estimated concurrently (28). The procedure for deconvolution entails 
prefitting via an automated waveform-independent technique (PULSE2). This method identifies 
presumptive pulses, by their significant reduction of the total fitted variance by F ratio testing 
(29). Provisional peaks were used in further multiparameter deconvolution analysis, wherein 
pulse number, position, amplitude, and hormone half-life are evaluated concurrently (6, 29). 
 
To avoid overdetermination of peaks (Nyquist concept), GH peaks that were closer than 20 min 
(2 sampling intervals apart) were eliminated, and the data were refit. In addition, any peaks that 
were outside the sampling window (0–360 min) by more than one sample interval (10 min) were 
eliminated. A secretory burst was approximated algebraically by a Gaussian distribution of 
secretory rates (28). Basal (nonpulsatile) secretion was estimated concurrently, from the 
preexercise baseline data, as previously described (29). GH secretory pulses were considered 
significant if the fitted amplitude (maximal value attained within the computed secretory event) 
could be distinguished from zero with 95% statistical confidence. The half-duration of the GH 
secretory pulse (defined as the duration in minutes of the calculated secretory burst at half-
maximal amplitude), GH half-life, and GH distribution volume were assumed to be constant 
throughout any one study period in an individual. The mass of GH secreted per pulse is the 
integral of the calculated secretory pulse (in μg/l distribution volume) (28). The pulsatile GH 
production rate was defined as the product of the number of GH secretory pulses and the mean 
mass of GH secreted per pulse. The 90-min GH burst mass was calculated as the summed 
secretion during and after exercise (0900–1030 h). 
 
Statistical analysis. ANOVA with repeated measures over exercise intensity was used to 
examine mean differences in V˙o2 and blood lactate concentrations. Whenever mean differences 
were observed, mean comparisons (corrected for correlated data with the use of Huynh-Feldt 
epsilons) were examined. To examine the relationship between GH response and exercise 
intensity, separate regression models were estimated for each of the eight study subjects with the 
GH response regressed on exercise intensity. Separate models were estimated within subjects 
because of the intraindividual correlation that existed among the GH responses across levels of 
exercise intensity. Such methods, although likely to be conservative, were thought to be 
appropriate because of the limited sample size that was available for estimating intra-individual 
correlation structures. Simple linear regression was also used because, compared with more 
complex models that allow for curvature, departures from linearity were not apparent. To 
determine whether a GH response changed significantly with exercise intensity, the eight slopes 
associated with exercise intensity from the individual regression models were then subjected to a 
Wilcoxon signed-rank test (12). Similar methods were used to examine the association between 
each of the deconvolution parameters and exercise intensity. The relationship between exercise + 
recovery (0900–1300 h) serum IGHC values and exercise intensity was further assessed by 
adding each deconvolution parameter to the within-subject regression models. To determine 
whether the relationship between the GH response and exercise intensity was independent of a 
deconvolution parameter, the slopes associated with exercise intensity in the adjusted models 
were subjected to a Wilcoxon signed-rank test. 
 
RESULTS 
 
Subjects' V˙o2 peak was 45.6 ± 2.1 ml · kg−1 · min−1 (2.87 ± 0.25 l/min), V˙o2 at LT was 29.9 ± 2.7 
ml · kg−1 · min−1 (1.90 ± 0.19 l/min), V˙o2 at the LT-to-V˙o2 peak ratio was 0.66 ± 0.9, and percent 
body fat was 23.4 ± 2.6%. As previously reported in young men (20),V˙o2 at LT 
andV˙o2 peak were strongly correlated (r = 0.79). One-way ANOVA with repeated measures and 
post hoc analyses revealed that V˙o2and blood lactate concentrations increased (P < 0.05) across 
all exercise intensities. The meanV˙o2 value at each exercise intensity (0.25LT, 0.75LT, LT, 
1.25LT, and 1.75LT) corresponded to ∼33, 49, 62, 76, and 86% of V˙o2 peak, respectively. Thus, 
whether data were examined relative to LT or relative to V˙o2 peak, linear increments in exercise 
intensity were observed. 
 
Figure 1 shows mean serum GH concentrations from blood sampled at 10-min intervals over 6 h 
at rest and during 0.25LT, 0.75LT, LT, 1.25LT, and 1.75LT exercise. No differences were 
observed among conditions for baseline IGHC (0700–0900 h; P = 0.20). Baseline IGHC values 
ranged from 1 μg · l−1 · min−1 at LT to 45 μg · l−1 · min−1 at 0.25LT. Mean ± SE IGHC values (in 
μg · l−1 · min−1) during exercise + recovery were as follows: rest = 509 ± 126, 0.25LT = 799 ± 
131, 0.75LT = 1,013 ± 219, LT = 764 ± 97, 1.25LT = 954 ± 186, and 1.75LT = 1,459 ± 253. The 
highest GH values occurred during the 1.75LT condition. 
 
 
Fig. 1. Mean serum growth hormone (GH) concentrations during blood sampling at 10-min 
intervals over 6 h during C, 0.25LT, 0.75LT, LT, 1.25LT, and 1.75LT conditions. Values are 
means ± SE;n = 8 young women. C, control; 0.25LT and 0.75LT, 25% and 75% of the difference 
between O2 consumption (V˙o2) achieved at lactate threshold (LT) and V˙o2 at rest; LT, at lactate 
threshold; 1.25LT and 1.75LT, 25% and 75% of the difference between the V˙o2 achieved at LT 
and peakV˙o2. 
 
The individual relationships between exercise intensity and IGHC during exercise + recovery 
(0900–1300 h) are shown in Fig. 2. Within-subject regression revealed that IGHC increased 
significantly with each exercise intensity in a linear pattern (P = 0.016). This was the case when 
IGHC was plotted against either a percentage of LT (Fig. 2) or a percentage of V˙o2 peak (data not 
shown). There was no suggestion from the data that any of the individual GH responses 
increased differently across the ranges of exercise intensity. 
 
 
Fig. 2. Relationship between exercise intensity (expressed as a percentage of LT) and integrated 
serum GH concentration (exercise + recovery, 0900–1300 h). Symbols represent individual 
concentrations for 8 young women across 6 levels of exercise intensity. The thick solid line is 
derived from the average of the intercepts and slopes from the thinner within-subject regression 
lines. Integrated serum GH increases significantly with exercise intensity (P = 0.016). 
 
Table 1 shows the results of the multiparameter deconvolution analysis of serum GH 
concentrations between 0700 and 1300 h. GH production rate, mass of GH secreted per pulse, 
and GH secretory pulse amplitude all increased significantly with increasing exercise intensity 
(P = 0.032, 0.016, and 0.016, respectively). 
 
Table 1. Effects of increasing exercise intensity on specific measures of GH secretion and half-
life during 6 h (0700–1300) in young women as determined by multiple-parameter 
deconvolution analysis and regression analyses 
Variable C 0.25LT 0.75LT LT 1.25LT 1.75LT XSlope X Intercept 
IGHC, μg · l−1 · 
min−1 510 ± 126 799 ± 131 1,014 ± 219 764 ± 97 955 ± 186 1,459 ± 253 
449.98 ± 
79.6* 562.3 ± 112.2 
GH basal secretion, 
μg/lv 
0.008 ± 
0.002 
0.005 ± 
0.002 
0.012 ± 
0.003 
0.008 ± 
0.001 
0.007 ± 
0.002 
0.006 ± 
0.001 
0.0024 ± 
0.001 
0.0077 ± 
0.001 
No. of GH secretory 
pulses 8.4 ± .6 6.5 ± .7 6.8 ± .6 5.9 ± .6 5.6 ± .4 6.3 ± .7 −1.09 ± .57 7.47 ± .54 
GH mean interpulse 
interval, min 40.0 ± 2.2 50.9 ± 6.0 43.4 ± 4.1 54.3 ± 7.1 47.3 ± 5.9 47.2 ± 3.3 2.6 ± 3.5 45.05 ± 3.5 
GH secretory pulse 
half-duration, min 18.0 ± 2.4 23.7 ± 2.5 17.6 ± 1.5 19.3 ± 1.8 17.4 ± 1.3 18.4 ± 1.9 −1.41 ± .84 20.2 ± .94 
GH half-life, min 16.1 ± 1.3 16.8 ± 1.0 14.7 ± 1.1 14.9 ± .86 16.8 ± .78 15.7 ± 1.1 −0.52 ± 0.76 16.1 ± .75 
Mass of GH/pulse, 
μg/lv 
3.3 ± .5 8.2 ± .91 8.3 ± 2.4 7.1 ± 1.0 8.3 ± .82 11.0 ± 2.4 3.14 ± 1.2* 5.01 ± .99 
GH secretory pulse 
amplitude, μg/lv 
0.18 ± .03 0.33 ± .03 0.43 ± .09 0.41 ± .09 0.42 ± .06 0.60 ± .06 0.20 ± .03* 0.22 ± .04 
GH production rate, 
μg · lv−1 · min−1 
26.2 ± 3.5 51.0 ± 4.6 53.3 ± 14.3 39.6 ± 5.2 46.4 ± 5.8 77.2 ± 17.5 16.8 ± 7.7* 33.9 ± 5.5 
Values are means ± SE; n = 8 subjects. C, control; 0.25LT and 0.75LT, 25 and 75% of the difference between the 
O2 consumption (V˙o2) achieved at lactate threshold (LT) and theV˙o2 at rest; LT, at lactate threshold; 1.25LT and 
1.75LT, 25 and 75% of the difference between theV˙o2 achieved at LT and peakV˙o2; GH, growth hormone; lv, liter 
of distribution volume; X slope, mean of the slopes from the 8 individual regression lines; Xintercept, mean of the 
intercepts from the 8 individual regression lines. GH basal (nonpulsatile) secretion = linear secretion term (usually 
set to zero for purely pulsatile secretion pattern); basal fit for preexercise baseline data and then applied to exercise 
conditions. GH secretory pulses = number of significant secretory peaks per sampling session. GH mean interpulse 
interval: mean time between secretory peaks per sampling session. GH secretory pulse half-duration = duration of 
the calculated secretory event as half-maximal amplitude. GH half-life = clearance time. Mass of GH/pulse = area of 
the calculated secretory pulses (amount of hormone secreted per unit distribution volume). GH secretory pulse 
amplitude = maximal value attained within the computed secretory event. GH production rate = product of 
mass/pulse and number of bursts (plus any basal secretion). *P < 0.05. 
 
Because we have previously reported that the GH response to exercise was completed by 90 min 
in men (20), we examined the 90-min mean serum GH concentration after the stimulus (0900–
1030 h), the absolute serum GH peak response, and the summed mass of GH secreted per pulse 
over the same time period in women (exercise + 1-h recovery) (Fig. 3). Data for women in the 
present study revealed significant increases with exercise intensity for all three parameters (P = 
0.008). 
 
 
Fig. 3. Mean serum GH concentration (top), absolute maximal serum GH peak response 
(middle), and the summed GH mass secreted per pulse (bottom) over a 90-min interval (exercise 
+ 1-h recovery, 0900–1030 h) according to exercise intensity in women. The thick solid line is 
derived from the average of the intercepts and slopes from the thinner within-subject regression 
lines. The 90-min mean serum GH, peak GH, and summed mass secreted per pulse increase 
significantly with exercise intensity (P= 0.008, P = 0.008, and P = 0.008, respectively). 
 
DISCUSSION 
 
The findings of the present study are similar to our previous observations in young men (20) in 
that 1) exercise at all intensities stimulates greater GH release than that observed at rest, 2) the 
GH response to exercise is related to exercise intensity in a linear dose-response pattern, 3) 
augmentation of GH production with increasing intensity of exercise is attributable 
mechanistically to an increase in the mass of GH secreted per pulse, and 4) the number of GH 
secretory pulses and the GH half-life are not affected by exercise intensity. 
 
Because the present data in young women were collected concurrently with our previously 
reported findings in young men (20), we felt that it was reasonable to examine gender 
differences. The reason that the analysis of the data collected in young women was delayed was 
because admission to the GCRC was menstrual cycle dependent (e.g., all admissions occurred 
during the early follicular phase). Students' t-tests were used to compare descriptive 
characteristics, whereas Wilcoxon ranked-sums two-tailed tests were used to analyze the slopes 
and intercepts from the regression models related to exercise intensity and GH release. 
 
Men were significantly taller and heavier (20), and women had significantly more body 
fat.V˙o2 peak expressed per kilogram of body weight was not significantly different in men and 
women, but absolute V˙o2 peak was greater in men than in women (P < 0.05). There was no 
gender difference in treadmill velocity where LT occurred, in maximal heart rate, or in maximum 
blood lactate concentration. There was also no gender difference in V˙o2 at LT expressed as a 
percentage ofV˙o2 peak. 
 
Basal (nonpulsatile) GH secretion at rest was twofold greater in women (0.08 ± 0.002 μg · l−1 · 
min−1) than in men (0.004 ± 0.001 μg · l−1 · min−1; Ref.20), but no significant within-gender 
differences were observed across the five exercise and one control condition. Gender differences 
in basal pulsatile GH secretion at rest are well recognized throughout the human lifespan (7). We 
recently reported that both basal and spontaneous GH secretion rates are greater in young women 
than in men. The gender difference in spontaneous GH secretion was accounted for solely by 
augmented GH secretory burst mass (35). In the present study in women as well as in our 
previous report in men (20), we observed stable basal GH secretion across the control and five 
exercise conditions. This allowed valid comparison of exercise-stimulated GH secretion between 
gender. 
 
Women achieved higher serum GH concentrations at each exercise intensity compared with men 
(20) (P < 0.05). Statistical comparisons between gender revealed that women had greater mean 
slope (men = 277 ± 48, women = 449 ± 80) and intercept (men = 198 ± 62 μg · l−1 · min−1, 
women = 562 ± 112 μg · l−1 · min−1) values when the GH response was regressed on exercise 
intensity (P = 0.08 and P = 0.02, respectively) (Fig. 4). For each increase in exercise intensity 
corresponding to 0.25LT, the exercise + recovery IGHC (4 h) would be expected to increase by 
∼70 μg · l−1 · min−1 for men and by ∼121 μg · l−1 · min−1 for women. 
 
 
Fig. 4. Mean slope and intercept values when the GH response was regressed on exercise 
intensity in young men and women. The male data were taken from Ref. 20. 
 
Gender comparisons further revealed that women had a greater GH production rate than men 
(20) at rest and at each exercise intensity (P < 0.05). The mean mass of GH secreted per burst 
increased significantly with increasing exercise intensity in both sexes, with a trend for greater 
mass of GH secreted per burst in women (P = 0.09). Gender differences in GH secretory pulse 
amplitude were observed as women had a higher mean amplitude (0.22 ± 0.04 μg · l−1 · min−1 vs. 
0.08 ± 0.03 μg · l−1 · min−1, respectively) (P < 0.05). 
 
There were no significant differences in the mean interval between GH peaks or in GH half-life. 
The mean interval between GH peaks was ∼45 min, regardless of gender or exercise intensity. 
Men (20) demonstrated a decrease in GH half-duration with increasing exercise intensity, which 
was significantly different from women (P < 0.05). Gender differences were observed in GH 
peak frequency (P < 0.05). The frequency of peaks was approximately eight for women and 
approximately six for men. 
 
The regression models indicated that GH production rate during the 6-h period would be 
expected to increase by ∼2.6 μg · l−1 · min−1 in men (20) and by ∼5.26 μg · l−1 · min−1 in women 
for each increase in exercise intensity corresponding to 0.25LT. This was accounted for by an 
increase in the mass of GH secreted per pulse [∼0.50 μg/l (men) and ∼0.96 μg/l (women)] for 
each increase in exercise intensity corresponding to 0.25LT, with no change in the number of 
GH secretory pulses or the GH half-life of elimination. The amplitude (maximal secretory rate) 
of GH secretory pulses increased by ∼0.04 μg · l−1 · min−1 (men) and ∼0.05 μg · l−1 · 
min−1(women) with each 0.25LT increase in exercise intensity, whereas the secretory pulse half-
duration decreased by ∼1.1 min (men) and ∼0.28 min (women) with each increase in exercise 
intensity of 0.25LT. Thus, with increasing exercise intensities, GH secretory pulses were of 
shorter duration but greater amplitude. The positive relationship between exercise + recovery 
IGHC (0900–1300 h) and exercise intensity remained statistically significant after adjustment for 
each of the deconvolution parameters with the exception of a trend for GH secretory pulse 
amplitude (P = 0.106), suggesting that increased pulse amplitude is the primary statistical 
determinant of the increase in IGHC with increasing exercise intensity. 
 
Data previously reported for men (20) and for the women in the present study revealed that the 
90-min mean serum GH concentration, peak GH concentration, and the summed mass of GH 
secreted per pulse increased significantly with exercise intensity. Gender comparisons revealed 
that for this 90-min time frame women had greater slopes and intercepts for the relationship 
between exercise intensity and mean serum GH concentration (P = 0.02 and 0.102, respectively) 
and peak GH concentration (P = 0.02 and P = 0.004, respectively). 
 
None of the limited studies that have compared GH release during exercise in men and women 
has explored the impact of exercise intensity (16, 35). In the present analysis, we establish that 
women have a greater GH response than men at all levels of exercise intensity. We observed 
that, similar to our findings in men (20), the GH secretory response to exercise was related to 
exercise intensity in a linear dose-response relationship in women. The GH secretory response to 
exercise rose with increasing exercise intensities below the LT and continued to rise above LT 
(Fig. 2). Notably, as we recognized recently in men (20), exercise intensities below the LT 
stimulated GH release in women, suggesting that no threshold relationship exists in either sex 
between exercise intensity and the GH response. The finding that the magnitude of change in GH 
release with increasing exercise intensity is greater in young women than in young men (Fig. 4) 
extends corroborative observations based on a single intensity of exercise (16, 35). 
 
Maximal serum GH concentrations were reached within 20–40 min of onset of the (30-min) 
exercise bout in both men (20) and women. Other studies also observed that exercise-induced 
GH concentrations peak at or near the end of exercise (16,22). Likewise, as previously noted 
with exercise (5, 16,22, 24, 33) and other stimulation tests (8, 25), we observe considerable 
intersubject variability in peak serum GH values. 
 
Women had significantly greater GH peak number, production rate, and pulse amplitude 
(Table 1) than men (Ref. 20 and see Table1). In addition, we confirm the prior inference at a 
single exercise intensity (35) that women attain a maximal serum GH concentration more rapidly 
(Fig. 1) than men (Ref. 20 and see Fig. 1) under exercise drive, independent of exercise intensity. 
This may be related to a greater anticipatory response in women compared with men (34). This 
could reflect more rapid onset of endogenous GH secretagogue release and/or somatostatin 
withdrawal in women (7). The results of gender differences in GH production rate mirrored the 
results for IGHC (we used IGHC as a complementary and model-free measure of GH release). 
Thus the gender difference is robust to the method of analysis. 
 
Akin to previous reports (10, 26, 30), there was no gender difference in mean GH interpulse 
interval or GH half-life. There was also no significant interaction between gender and mean mass 
of GH secreted per burst, although there was a trend for a main effect of gender (P < 0.10). Van 
der Berg et al. (26) did report that a higher mass of GH was secreted per burst in women than in 
men. However, van den Berg et al. examined a full 24-h profile of resting data with intercurrent 
food intake. In the present study, gender differences may have been more pronounced if the data 
collection had lasted longer than 6 h. In addition, in the present study, subjects fasted from 2100 
to 1300 overnight and during sampling. Whether gender and fasting control GH release in an 
interactive fashion is not known (9). 
 
As a time-limited measure of the effects of exercise on GH secretion, we calculated the 90-min 
mean serum GH concentration, peak GH level, and summed mass of GH secreted per pulse 
(Fig. 3). Each parameter increased significantly with escalating exercise intensity. Women 
continued to maintain greater responsiveness to exercise than men (Ref.20 and see Fig. 3) with 
increasing exercise intensity (significant differences occurred for mean serum GH and peak GH 
concentrations). Analogously, exercise and l-arginine infusion stimulated GH release more in 
women than in men (35). If l-arginine decreases somatostatin outflow, exercise may stimulate 
GH release in part via withdrawal of somatostatin inputs, especially in men. Accordingly, the 
present gender distinction in exercise effects may reflect unequal somatostatin tone in men and 
women. The latter notion is consistent with early studies that suggest that GH release in response 
to arginine is greater in women than in men at rest (18, 35). 
 
It should be realized that the findings of the present study are limited to young adults. Whether 
these findings remain consistent in middle-aged or older adults or in individuals with chronic 
disease cannot be addressed with the present data. 
 
In summary, the present study delineates that young women maintain a linear relationship 
between the magnitude of GH release and increasing exercise intensity. The inferred dose-
response relationship is robust to standardization against either LT orV˙o2 peak. Moreover, gender 
comparisons establish that exercise-induced GH release is greater in women than in men. This 
sex contrast reflects an increased number and amplitude of GH secretory pulses during exercise 
in women, with no difference in estimation of GH half-life. In both genders, the augmentation of 
GH production rates with increasing intensity of exercise is attributable mechanistically to an 
increase in the mass of GH secreted per pulse. The latter response mode is consistent with 
somatostatin withdrawal and/or augmented release of endogenous GH secretagogues. 
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